Centro de Cancer Pontificie Universidad Catolica de Chile

Santiago 8330074

0 studies enrolling now · 1 studies all time

What they study most

Triple Negative Breast Cancer

Studies at this site

• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) — Completed